Sept 2 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* To acquire Synergetics USA
* Deal for $6.50 per share in cash
* In addition to upfront cash payment, Synergetics stockholders will receive
additional cash payments of up to $1.00 per share
* Synergetics stockholders will receive additional cash payments if specified
sales milestones are achieved following the closing
* Tender offer and withdrawal rights are expected to expire on 20th business
day after launch of offer
* Transaction is expected to close in the fourth quarter of 2015
* $0.50 per share in cash payable upon sales of co's ophthalmology products
achieving $55 million on trailing 4 quarter basis prior to June 30, 2018
* Pharma international - $0.50 per share in cash payable upon sales of
ophthalmology products achieving $65 million on trailing 4 calendar quarter
basis
* Pharma international - after successful completion of offer, co to acquire
remaining shares not tendered in offer through second-step merger
* Source text for Eikon ID:nCNWgqXTfa
* Further company coverage VRX.TO